The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Session information

Symposium

[S34] Copper ion: Its relevance to diseases, its detection and control

Mon. Mar 29, 2021 9:30 AM - 11:30 AM [Room D] Oral Presentation D (Online)

Organizer: Higuchi Tsunehiko (Nagoya City University), Komeda Seiji (Fac Pharm Sci, Suzuka Univ.)

Copper is imminent metal contacting than daily life as ingredients of money and an electric wire, brass and bronze. Copper is also one of the main transition metal. This element is the trace element which is essential to the animals and plants as an active center of many enzymes and a signal, playing various roles in vivo function. On the other hand, recently, a number of studies have revealed that copper should be related to the many diseases including a neurodegenerative disease and cancer. As for copper ion, connection with the oxidation stress is discussed to produce reactive oxygen species by a reaction with hydrogen peroxide like an iron (II) ion. Therefore, this symposium would help for future study concerning copper by overlooking the big picture by making copper a topic from plural viewpoints. At first it begins in a copper chemical characteristic and gives outline about molecules controlling the basics of reactive oxygen species, oxidation stress to be concerned with of the copper ion, connection with the carcinogenesis. Next lecture will give the development of the fluorescent probe detecting intracellular copper(I). Furthermore, next two lectures will give about nerve cells injury caused by copper. We aim at performing general discussion helpful for the development to drug discovery, life sciences concerning future copper studies.

総合討論:米田 誠治(鈴鹿医療大薬) (11:10 AM - 11:30 AM)

×

Authentication

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

×

Please log in with your participant account.
» Participant Log In